Intuitive Surgical, Inc. (ISRG) Announces the Completion of its Acquisition of the da Vinci and Ion Distribution Business

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best stocks that will always grow.

Intuitive Surgical, Inc. (NASDAQ:ISRG) announced on March 2 the completion of its acquisition of the da Vinci and Ion distribution business operated by ab medica, Abex, Excelencia Robótica, and their affiliates. The company now wholly owns the da Vinci and Ion business of ab medica, Abex, and Excelencia Robótica, with business operations integrated into Intuitive Surgical, Inc.’s (NASDAQ:ISRG) European commercial and marketing organization. Management stated that the completion marks the formal expansion of the company’s direct operations in Europe.

Intuitive Surgical, Inc. (NASDAQ:ISRG) further reported that the combined installed base of da Vinci surgical systems in Italy, Spain, and Portugal as of December 31, 2025, exceeds 470, with the Ion endoluminal system recently launched in Italy and Spain.

Intuitive Surgical, Inc. (NASDAQ:ISRG) previously reported that the da Vinci 5 system was cleared by the U.S. Food and Drug Administration (FDA) has cleared the da Vinci 5 system for certain cardiac procedures, including mitral valve repair and IMA (internal mammary artery) mobilization for cardiac revascularization, on January 26.

Intuitive Surgical, Inc. (NASDAQ:ISRG) has an elaborate ecosystem of services and products that provide robotic-assisted surgical solutions and invasive care. Its products include the Ion Endoluminal and the Da Vinci Surgical systems.